Ubs Asset Management Americas Inc Zai Lab LTD Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 18,171 shares of ZLAB stock, worth $312,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,171
Previous 13,466
34.94%
Holding current value
$312,904
Previous $368,000
20.92%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ZLAB
# of Institutions
124Shares Held
39.9MCall Options Held
41.2KPut Options Held
190K-
Wellington Management Group LLP Boston, MA6.66MShares$115 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA5.68MShares$97.9 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$76.3 Million0.04% of portfolio
-
Woodline Partners LP San Francisco, CA2.6MShares$44.7 Million0.4% of portfolio
-
Viking Global Investors LP2.05MShares$35.3 Million0.12% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $1.69B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...